BARBIERI, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 1.306
AS - Asia 848
EU - Europa 776
SA - Sud America 315
AF - Africa 39
OC - Oceania 6
Totale 3.290
Nazione #
US - Stati Uniti d'America 1.254
SG - Singapore 387
BR - Brasile 273
IT - Italia 158
CN - Cina 151
IE - Irlanda 148
HK - Hong Kong 129
SE - Svezia 126
DE - Germania 68
PL - Polonia 49
IN - India 46
VN - Vietnam 45
FI - Finlandia 34
EE - Estonia 32
CA - Canada 31
FR - Francia 25
GB - Regno Unito 25
RU - Federazione Russa 21
IQ - Iraq 15
NL - Olanda 15
AR - Argentina 13
ES - Italia 13
MX - Messico 13
ZA - Sudafrica 13
BD - Bangladesh 12
BE - Belgio 12
JP - Giappone 12
ID - Indonesia 11
AT - Austria 10
MA - Marocco 8
CO - Colombia 7
TR - Turchia 7
UA - Ucraina 7
CI - Costa d'Avorio 6
CL - Cile 5
EC - Ecuador 5
LT - Lituania 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
PA - Panama 4
PY - Paraguay 4
CH - Svizzera 3
EG - Egitto 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
PK - Pakistan 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
PT - Portogallo 2
SN - Senegal 2
TW - Taiwan 2
UZ - Uzbekistan 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MU - Mauritius 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PW - Palau 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TO - Tonga 1
Totale 3.290
Città #
Ashburn 248
Dallas 228
Singapore 205
Chandler 161
Dublin 147
Hong Kong 129
Beijing 66
Nyköping 65
Los Angeles 51
Messina 50
Warsaw 47
Munich 38
The Dalles 36
São Paulo 27
Hyderabad 22
New York 22
Turku 21
Princeton 19
Medford 18
Ho Chi Minh City 16
Redondo Beach 15
Buffalo 14
Frankfurt am Main 14
Rome 14
Seattle 14
Brooklyn 12
Brussels 12
Dearborn 12
Denver 11
Des Moines 11
Montreal 11
Amsterdam 10
Moscow 10
Stockholm 10
Baghdad 9
Belo Horizonte 9
Jacksonville 9
Paternò 9
Rio de Janeiro 9
Helsinki 8
Jakarta 8
London 8
Tianjin 8
Tokyo 8
Vienna 8
Wilmington 8
Catania 7
Hanoi 7
Milan 7
Salvador 7
Santa Clara 7
Abidjan 6
Boston 6
Bremen 6
Chennai 6
Houston 6
Nuremberg 6
Orem 6
Pune 6
Changsha 5
Johannesburg 5
Lamezia Terme 5
Mexico City 5
Mumbai 5
Toronto 5
Atlanta 4
Bari 4
Bexley 4
Boardman 4
Brno 4
Calgary 4
Campinas 4
Columbus 4
Coronel Fabriciano 4
Dong Ket 4
João Pessoa 4
Poplar 4
Brasília 3
Charlotte 3
Chiang Mai 3
Curitiba 3
Fairfield 3
Fortaleza 3
Guangzhou 3
Istanbul 3
Jinan 3
Lappeenranta 3
Lauterbourg 3
Livorno 3
Miami 3
Montevideo 3
Muscat 3
New Delhi 3
Osasco 3
Pittsburgh 3
Ponta Grossa 3
Porto Alegre 3
Presidente Prudente 3
San Francisco 3
Santiago 3
Totale 2.117
Nome #
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 155
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 152
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 146
Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment 133
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 120
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 119
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 118
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 114
Clinically Relevant Drug Interactions Between Statins and Antidepressants 106
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 106
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 101
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 101
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 98
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 96
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 95
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 94
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 94
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 89
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 88
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants 86
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 80
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 77
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System 64
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 63
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 61
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 58
Management of patients with inflammatory bowel diseases: evaluating effectiveness, safety, and drug repurposing strategies 58
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience 57
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance 55
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues 53
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 49
The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: an analysis of the SPIN-UTI project from 2006 to 2021 48
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia 47
Artificial intelligence for the optimal management of community-acquired pneumonia 41
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 40
Drug Repurposing in Crohn’s Disease Using Danish Real-World Data 38
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 37
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data 34
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points 32
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 30
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database 30
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 29
Drug Safety and Relevant Issues in the Real-World 25
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure 25
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review 24
Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction 22
null 22
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 1
Totale 3.411
Categoria #
all - tutte 13.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 5 5 8 6 23 0 4
2021/2022168 5 13 0 2 10 9 8 7 0 47 5 62
2022/2023476 33 56 20 51 26 43 7 49 174 1 14 2
2023/2024185 12 16 23 13 12 33 19 8 4 25 6 14
2024/20251.143 21 17 28 72 37 54 68 188 228 121 152 157
2025/20261.281 223 177 303 261 286 31 0 0 0 0 0 0
Totale 3.411